LISSSD 2025 Anneka Anderson
Waipapa Taumata Rau/ University of Auckland, NZ, New Zealand
- This delegate is contactable by email.
- This delegate is presenting an abstract at this event.
Presentations this author is a contributor to:
High dose, subcutaneous injections of benzathine penicillin G (SCIP) to prevent rheumatic fever: A single arm, phase IIa trial of safety and pharmacokinetics (116419)
10:03 AM
Julie Bennett
Plenary 5 - Interventions for Prevention
Setting the scene for Group A Streptococcus vaccine studies: The complete clinical spectrum of severe acute disease is present in Auckland, Aotearoa New Zealand (#117)
5:30 PM
Andrew Fox-Lewis
Poster Session 1
Subcutaneous injections of penicillin: Convenient and effective treatment for Māori, Pacific Peoples and their whānau in preventing rheumatic heart disease (#273)
5:30 PM
Julie Cooper
Poster Session 2
Tracking the relationship between community Strep A infections and Acute Rheumatic Fever in Auckland, New Zealand: 2018-2024 (#103)
5:30 PM
Julie Bennett
Poster Session 1
"iSOoTH: A study on children's sore throats to inform the development of a Group A Streptococcal vaccine (#166)
5:30 PM
Julie Bennett
Poster Session 1
Building laboratory capacity to advance Strep A vaccine development in Aotearoa New Zealand (#189)
5:30 PM
Aimee Paterson
Poster Session 1
The Emergence and Impact of M1UK on Invasive Group A Streptococcus Disease in Aotearoa New Zealand (#154)
5:30 PM
Anna Vesty
Poster Session 1
Rapua te mea nagro ka tau- a qualitative, Indigenous-informed approach to vaccine development. (118028)
2:42 PM
Anneka Anderson
Plenary 3 - Big Picture Vaccine Development
Rapua te mea ngaro ka tau: culturally responsive governance applied to vaccine development (#277)
5:30 PM
Shannon Leilua
Poster Session 2